#1signifyhealth. Investor Presentation February 2021 -> Homeward.#2→> Forward Looking Statements -> This presentation contains forward-looking statements that reflect our current views with respect to, among other things, the operations and financial performance of Signify Health, Inc. and its subsidiaries (collectively, the "Company", "Signify Health", "we" or "our"). All statements other than statements of historical facts contained in this presentation, including statements regarding matters such as our industry, business strategy, goals, and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity and capital resources and other financial and operating information, may be forward-looking statements. We may, in some cases, use the words "may," "might," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue," the negative of these terms and other comparable terminology to identify forward-looking statements in this presentation. These forward-looking statements contained in this presentation, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. Although we believe that the assumptions underlying the forward-looking statements are reasonable, there can be no assurance that management's expectations, beliefs and projections will result or be achieved. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including: the COVID-19 pandemic; our dependence upon a limited number of key customers; our dependence on certain key government programs; our failure to maintain and grow our network of high-quality providers; our failure to continue to innovate and provide services that are useful to customers and achieve and maintain market acceptance; our limited operating history with certain of our solutions; our failure to compete effectively; the length and unpredictability of our sales cycle; failure of our existing customers to continue or renew their contracts with us; seasonality that may cause fluctuations in our sales and results of operations; our failure to achieve or maintain profitability; our revenue not growing at the rates they historically have, or at all; our failure to successfully execute on our growth initiatives, business strategies, or operating plans; inaccurate estimates and assumptions used to determine the size of our total addressable market; changes in accounting principles applicable to us; incorrect estimates or judgments relating to our critical accounting policies; increase in our level of indebtedness; our failure to effectively adapt to changes in the healthcare industry, including changes in the rules governing Medicare or other federal health care programs; our failure to adhere to complex and evolving governmental laws and regulations; our failure to comply with current and future federal and state privacy, security and data protection laws, regulations or standards; our employment of and contractual relationships with our providers subjecting us to licensing or other regulatory risks; adverse findings from inspections, reviews, audits and investigations from health plans; inadequate investment in or maintenance of our operating platform and other information technology and business systems; security breaches or incidents, loss or misuse of data, a failure in or breach of our operational or security systems or other disruptions; disruptions in our disaster recovery systems or management continuity planning; our ability to comply with, and changes to, laws, regulations and standards relating to privacy or data protection; our ability to obtain, maintain, protect and enforce our intellectual property; our dependence on distributions from Cure TopCo, LLC to fund dividend payments, if any, and to pay our taxes and expenses, including payments under the Tax Receivable Agreement; our status as a controlled company; and our ability to realize any benefit from our organizational structure. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, our actual results may vary in material respects from those projected in these forward-looking statements. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not outside the control of the Company. Any forward looking statement made by us in this presentation speaks only as of the date of this presentation and the Company does not undertake any obligation to update these forward-looking statements. This presentation contains certain financial measures not presented in accordance with generally accepted accounting principles in the United State ("GAAP"), including Adjusted EBITDA, which is used by management in making operating decisions, allocating financial resources, and internal planning and forecasting and for business strategy purposes. Adjusted EBITDA is not a measure of financial performance in accordance with GAAP and may exclude items that are significant in understanding and assessing our financial results. Therefore, this measure should not be considered in isolation or as an alternative to GAAP measures. Our presentation of Adjusted EBITDA may not be comparable to similarly-titled measures used by other companies. Management believes that such measures are commonly reported by issuers and widely used by investors as indicators of a company's operating performance. There are other non-GAAP financial measures which should be considered only as a supplement to, and not as a superior measure to, financial measures prepared in accordance with GAAP. Please refer to the Appendix of this document for a reconciliation of Adjusted EBITDA to the most directly comparable financial measure prepared in accordance with GAAP. This presentation includes market and industry data and forecasts that we have derived from independent consultant reports, publicly available information, various industry publications, other published industry sources, and our internal data and estimates. Independent consultant reports, industry publications, and other published industry sources generally indicate that the information contained therein was obtained from sources believed to be reliable. The inclusion of market estimations, rankings, and industry data in this presentation is based upon such reports, publications, and other sources and our internal data and estimates and our understanding of industry conditions. Although we believe that such information is reliable, we have not had this information verified by any independent sources. You are cautioned not to give undue weight to such estimates. All trademarks, service marks, and trade names appearing in this presentation are the property of their respective holders. signifyhealth 2#3--> Healthcare is undergoing a tectonic shift Unsustainable trends... signifyhealth. ~$4T U.S. healthcare spend outpacing GDP growth 80% of rapidly growing 65+ population has a chronic condition >30% Readmission rates for BPCI-A patients ... Driven by a broken model... Facility- centric Break-fix model (fee-for-service) Poor patient engagement Pushing catalysts for change in Untethering toward the home and virtual 60%-70% U.S. healthcare spending expected to based care by 2025 Preventative, holistic model (value-based) 72% of patients prefer in- recovery -40% growth of mobile / digital ealth management 3#4Propelling the rise of value-based programs where Signify's -> platform helps enable our partners' success Value-based programs we help enable are thriving Medicare Advantage (MA) Managed Medicaid BPCI-A Episodes (Bundled Payment for Care Improvement - Advanced Model) ACO (Accountable Care Organizations) Commercial Episodes (Bundled Payment for Payors & Employers) signifyhealth. .. Our mission Transform how care is paid for and delivered so that people can enjoy more healthy, happy days at home Signify Platform Our vision To build a healthier place for us all to live and age in Clients are succeeding in value- based care on our platform Humana. OAK STREET HEALTH BETTER EVERY DAY OPTUM™ CENTENE Corporation WellCare Regence A Ascension Devoted Health UHS Anthem. Geisinger Trinity Health Beaumont Advent Health SENTAR A MEMORIAL ORLANDO HERMANN HEALTH STATE OF LG Oscar HEALTH BAPTIST EmblemHealth Intermountain Healthcare Bristol Myers Squibb Independence ECTICUT aetna CAMBIA HEALTH SOLUTIONS TENSTULE LINLIST ST. JOSEPH Regional Medical Center Priority Health HCSC Health Care Service Corporation 4#5--> "Homeward": what it means for Signify Helping individuals stay healthy & independent at home Home & Community Services ପଠ III We've focused on activating the home as a key part of the care continuum In-home evaluative services ~1.4M signifyhealth. in-home evaluations (¹) 7 Diagnostic & preventative services Healthy days at home Clinical & social care coordination Manage individuals in an episode and drive recovery home Episodes of Care Services Episodes of care services $6.1B ~15% episodes program size (2) more discharges home (3) Fueling double-digit growth with strong margins and cash flow 1) Preliminary estimated results as of, or for the year ended 2020. Actual results may differ materially from this preliminary estimated data 2) For the year ended 2019 3) Results represent At Risk episodes in BPCI Advanced initiated during 2019Q4 compared to the historical performance of similar episodes. Performance period statistics are based on BPCI Advanced claims provided by CMS in November 2020 VALUE-BASED CARE PLATFORM DRIVING OUTCOMES 2 Post-acute mgmt. services -10% reduced readmissions (³) 5#6The Signify platform combines analytics, networks, and --> technology to power and create value-based arrangements * signifyhealth Data Capture & Analytical Insights Networks Driving Holistic Care Technology- Enabled Actions 1) As of, or for the nine months ended 9/30/2020 signifyhealth. Algorithms powering insights on 35M members in our data chassis (1) Decision support pathways Savings opportunity analyses ... -9,000 physicians & nurses deployable to all 50 states 200m community-based organizations Network Enablement Smart applications Device hub Logistics & routing Consumer Engagement Segmentation Outreach Coordination ...... 3,500 (1) value-based provider sites 200¹) clinical & social care coordinators Episodes of Care Programs Optimization Pricing & payment. Sharing in risk Prevention of adverse events Holistic condition management Aligned payment incentives Healthy days at home 6#7-> Our platform creates a flywheel effect driving improvement and growth within value-based programs. ■ ■ ■ I I Extensive capture beyond traditional data sets into the home and community Real-time data from providers, payors, and CMS Reduce unnecessary facility time More healthy days at home Better consumer experience Shared program savings signifyhealth. Appropriate payment for risk assumed 1 Capture Data Improve Outcomes 4 2 Generate Insights Deliver Actions 3 ■ ■ Risk stratification and predictive modeling Targeted consumer engagement Site-of-care optimization Incentive alignment Access and coordination across care continuum: ambulatory, acute, post-acute and the home Holistic care model: clinical, social, and behavioral 7#8-> Leading platform powering Medicare Advantage ~1.4 million (¹) unique in-home evaluations performed nationwide in 2020 ■ Payor data (claims, eligibility, demographic, pharmacy, labs, provider, outreach, quality, diagnosis, MMR, MOR, RAPS, etc.) Compounding data from in-home visit (evaluation, meds, SDOH, diagnostic data) Social care coordination data from community-based network actions AGU NO Enabling consumers to receive holistic preventative services extending the PCP in the comfort of their home Healthy days at home Capture Data signifyhealth. Improve Outcomes ✔MA plans able to manage benefits and capitated payments for beneficiaries based on comprehensive capture of individuals' health & risk profiles Quality (e.g. Star, HEDIS gap closure) and consumer experience 1) Preliminary estimated results as of, or for the year ended 2020. Actual results may differ materially from this preliminary estimated data 2 Physics Generate Insights Deliver Actions Michigan Provider Availability Aity Be 12/12/201 wy Map Data 81773 umber 0 POTool, Shaun Number of co 0 Pant Pri Yer un espon HL A AA ■ Member risk stratification I ■ I ■ I ■ Al-driven acceptance modeling Consumer engagement profiling Socioeconomic insights informing needs from community networks Logistics & routing algorithms to optimally deploy providers to the home In-home evaluation (IHE) Diagnostic testing & screening services via device hub Medication review SDOH assessment and social care coordination to close loop PCP/specialist follow-up ■ Telehealth evaluation 8#9Leading platform powering episodes of care in BPCI-A -> $6.1B¹program spend under management in 2019 ■ I Claims and CMS data EMR and practice management system data Signify's episode application data (historical and benchmark data from amassed episode volume) 1) As of, or for the year ended 2019. Site of Care signifyhealth. Site of Game Utration by Procedur Oynar Improved patient outcomes... Unnecessary readmissions Days in acute or high-cost post acute facilities Discharges home. Days at home ... and results for value-based participants Shared savings for participating providers and Signify NOF Capture Data Improve Outcomes 2 AAE Savings Opportunity Across Episodes Episode Name Hip Replacement & Hip Revision Knee Arthroscopy Knee Replaceme Program Performance Knee Revision Lumbar Laminec Lumbar Spine Fu Generate Insights Deliver Actions Episodes 3000 60 Episodes per Month 556 (avg/mth ■ ■ ■ Episodes with on AAF Sovings Opportunity 10 10 Discharged to SNE 10.1% SNF Days 9.8 Days 17.4 Bere 3,337 pi Episodes wa Readmission 21:2% 1.1% 189 314 JUN B TOU Se $35,000 $35,000 707 10 Day Readin OFF Boy 19 PAIN 110 DE TR JA I ■ Opportunity analyses to inform savings potential and program design Prediction engine for timely identification of patients attributed to episodes Performance analytics to inform care redesign Predictively identify episodes for timely management of performance levers and the patient's care journey Deliver provider workflow, connectivity, and decision support to track and manage an episode Coordinate the right next-site-of-care and facility length-of-stay to drive program performance and episode savings 9#10Our homeward-focused platform powers improved outcomes and →> growth in episodes and other value-based programs Combined platform Tech-enabled holistic networks and services in the home CENSEOHEALTH signifyhealth. Capture Data Improve Outcomes ADVANCE TAVHealth HEALTH 2 Generate Insights Deliver Actions Episode-based incentives 3 alignment R Remedy Amplifying improved outcomes Preventative services at home Quality of care & experience Admissions to hospital / ED Unnecessary readmissions Days in acute or post acute facility Discharges home Days at home. Driving revenue growth olo % Success and continued improvement in shared. savings Confidence to grow spend under management and diversify into new programs together with our risk- bearing partners 10#11Extending our leading platform into novel value-based arrangements. →> and growing participation by new healthcare constituents. Program Enablement Long-standing experience as a leading enablement platform for programs driving value-based payment innovation Supporting value-based programs In-Home Evaluations, Clinical & Social Care Coordination signifyhealth. Partnering in value-based programs Health plans in Medicare Advantage and Managed Medicaid Humana. aetna CENTENE OPTUM™™ Corporation CAMBIA OAK STREET HEALTH RETIEN EVEN IN Episode Bundled Payments Program Creation Leveraging our established infrastructure to launch novel program arrangements in commercial market Designing value-based programs Health system and provider group partner network in BPCI and BPCI-A Ascension UHS Advent Health Geisinger Beaumont Trinity Health Intermountain Healthcare Expanded Program Innovation in Commercial Market Novel commercial episode programs for payors & employers, covering procedural and chronic conditions 16 STATE OF JUSTINES CONTROLLER CAMBIA HEALTH SOLUTIONS superior healthplan 11#12--> Our addressable market is supported by strong tailwinds Enrollment in Addressable Programs Value-Based Spend Signify Estimated IHE's Conducted In 2020 79 million (1) Members Enrolled in Medicare Advantage and Medicaid Managed Care signifyhealth ~1.4 Million (3) $400 billion (²) Spend Under Value-based Care in Government and Private / Commercial Lines of Business -$142 billion (²) Spend Under Value-based Care Alternative Payment Models with Downside Risk 1) Reflects 2020 Medicare Advantage enrollment per CMS and 2018 Medicaid Managed care enrollment per Medicaid.gov 2) Health Care Payment Learning & Action Network 2018 Alternative Payment Model (APM) Report 3) Preliminary estimated results as of, or for the year ended 2020. Actual results may differ materially from this preliminary estimated data $6.1 billion Signify Episode Spend Under Management in 2019 60-70% of healthcare payments expected to be tied to value- based care by 2025 12#13We help solve healthcare's last mile problem of meeting --> consumers where they are Healthcare participant data ● ● ● Payors Health systems Government agencies Pharma & life sciences Employers Device companies 000 signifyhealth. 000 000 Signify technology & insights Mobile & cloud applications with decision support algorithms and integrated proprietary device hub C 11:05 AM Non July 24 <Schedule OME Sucoliers Medication Review Anal Diamoors 24,30% 479 HARR PMH Medication Review Firstname Lastname-93 yrs-Female Please review all medications is usual arees She the refigerator, medicine cabinet, purse, pockets, Does the individual take any prescription medications? Do they understand WHY they are taking the medictionis)? Has either of these inhibited medication use, in the last 6 months? Consider a Case Management referral Still In Use Budesonide 30mg www.com Snim 17388 2,000 TEAM DULoxetine HCL 30mg Access to a pharmacy 200 Cost Analytics to align incentives and engage consumers 31m AŬ #10015 Hydrocodone- Acetaminophen 30mg No + New Medication Levothyroxine Dodium 30mg O Pria Year Statuslesption Chengeset AL ======I Provider Availability y 12/12/2016 Aty and optimally deploy the right provider Mag Data 1779 Satelite EKG A PAD test Diabetic eye exams A A AA A A Actions through our flexible network SD + Comprehensive in- home evaluation Preventative diagnostic tests SDOH / social care coordination Transition-to-home services Telehealth evaluations 1) https://www.beckershospitalreview.com/finance/average-cost-per-inpatient-admission-tops-22k.html#:~:text=The%20average%20outpatient%20visit%20in, in % 20The%20Lancet%20Public%20Health 2) As of, or for the year ended 2019 3. Healthcare consumers Prevention (More healthy days at home) Prevented readmission in a BPCI-A episode saves ~$17,000 Prevented initial admission in a commercial episode saves ~$22,000(1) Return to care: >90% of members evaluated follow up with a primary care visit(²) 13#14-> Client case study: how Signify's integrated solutions drive outcomes in value-based episode programs. 2018 2019 2020 signifyhealth. partnered with Signify In-Home Evaluations (IHE) Tenured relationship as top strategic growth partner ● In-Home Diagnostic Services Add-on of peripheral artery disease (PAD) & ancillary testing ● CAMBIA HEALTH COLUTIONE IHE+ ● ● Deepening our engagement in the home with social care coordination Commercial Episodes Expanded partnership to launch novel episode-based arrangements, now live with providers in the region Harriet (illustrative patient journey) Health plan's Medicare Advantage member 71 yrs with complex comorbid illness; needs hip surgery from a recent fall Comprehensive understanding of Harriet and her conditions via IHE and device hub Assess and coordinate holistic care for Harriet to recover and stay healthy at home Engage Harriet and perform actions to prevent an adverse acute event Pre-Acute Transition Home ‒‒‒‒‒I ASC Prevent costly inpatient rehab or skilled nursing facility stay in post acute by transitioning her home Acute Prevent inpatient admission and divert Harriet to a lower cost ambulatory surgical center for her procedure IRF / SNF 14#15-> Leading nationwide scale with ability to send clinicians into every county and state across the U.S. Networks -9,000 (²) mobile providers 200 (²) community sites. 500 (²) health systems & provider groups 3,000 (2) post acute facilities 200 (²) social & clinical care coordinators Actions signifyhealth. ~1.4M (1) in-home evaluations ~1M (2) cumulative episodes managed -260K (²) members assisted with SDOH services Data & Insights -50M (²) episode data transactions per month ~50M (²) map API calls routing providers to homes -35M (2) members in our database 1) Preliminary estimated results as of, or for the year ended 2020. Actual results may differ materially from this preliminary estimated data 2) As of the nine months ended 9/30/2020 Hospitals & Provider Groups Community Sites Home Health Agencies Mobile Clinicians. Skilled Nursing Facilities 15#16Signify Health: a leading platform powering and creating value-based payment programs signifyhealth. Significant access to the home Full care continuum engagement Platform with flyw heel effect driving outcomes at nationwide scale S - Lºd Capture Data Improve Outcomes Generate Insights Deliver Actions 3 * Large market to grow and create value-based programs across existing clients and new markets Large adaptive networks driving holistic care Aligned incentives via episode and other value-based arrangements 16#17Compelling growth path and strong financial performance signifyhealth. 17#18--> Multiple drivers of financial performance Robust top line growth and attractive EBITDA margin signifyhealth. Continued margin expansion to fund growth and diversification Differentiating combination of scale, growth, and profitability We believe strong core volume and program size growth drives predictable, visible business model Still scratching the surface in value-based care TAM Efficient balance sheet with low leverage 18#19->Compelling revenue model (illustrative examples) Helping individuals stay healthy & independent at home Home & Community Services Based on per member evaluated (or other preventative action performed) Often performed during evaluation signifyhealth. # of evaluations # of diagnostic add-on services completed # of biopharma assessments # of IHE+ (social care coordination) engaged X X X X per per per Healthy days at home per M HCS revenue Manage individuals in an episode and drive recovery home Episodes of Care Services Based on generation of cost savings with partners 2.0% To provider 2.0% To Signify 8.5% 3.0% Gross savings rate To payor 1.5% Admin fee to Signify Į % Savings Spend under rate management Episode revenue 19#20Deep and diversified anchor customer base with attractive --> growth levers Payors Health systems & provider groups signifyhealth. New entrants Humana. OPTUM™ aetna Anthem. HIGHMARK. CAMBIA HEALTH SOLUTIONS OAK STREET Oscar HEALTH BAPTIST HEALTH EmblemHealth Corporation SENTARA" Advent Health √ UHS Geisinger Trinity Health Pharma Ill Bristol Myers Squibb & NOVARTIS Priority Health Regence MEMORIA Ascension of Tennessee ST. JOSEPH Regional Medical Center parexel juno THERAPEUTICS WellCare Independence HCSC ORLANDO HEALTH Sinai Health System Intermountain Healthcare OF Employers CONN STATE C Beaumont ERNETO Blue Cross Blue Shield Blue Care Network of Michigan FRANS TUL COMPTROLLER Multiple levers for growth Headroom to deepen wallet share Ability to improve program performance X Cross-sell of new services and VBC programs New customers 20#21->The "network effect" as we stack value-based programs As we recruit and "light up" provider participants for one payor's program... Engagement of more individuals each year in the home unlocks access... Payor 1 "Anchor" Payor 2 Signify Platform Activated provider network nodes: signifyhealth - Ambulatory facilities Acute facilities Post acute sites Community organizations OR Performance benefits CA WA NV UT new programs "stacked" in the same region benefit from network nodes already activated in our platform AZ MT WY NM CO a ● ~9,000 (¹) MDs & NPs mobilized nationwide Speed to value ~1.4M (²) unique in- home visits in 2020E 1) As of the nine months ended 9/30/2020 2) Preliminary estimated results as of, or for the year ended 2020. Actual results may differ materially from this preliminary estimated data Ba Solda laa Canula de Zaragoce Marylan Maryland ... to cross-sell and stack new programs and preventative services, while more optimally utilizing network resources Improved efficiencies District of Rhode Island 21#22-> Attractive financial model, growth, and profitability Revenue (¹) ($ in millions) signifyhealth. $502 2019 +20 - 22% $600 - $610 Preliminary 2020 Range (3) Adj. EBITDA (1,2) ($ in millions) $93 2019 +28 -32% 1) Remedy acquisition completed on 1/15/2019 2) We define Adjusted EBITDA as net income (loss) before interest expense, income tax expense, depreciation and amortization and certain items of income and expense, including asset impairment, other (income) expense, net transactions-related expenses, equity-based compensation, remeasurement of contingent consideration, management fees and non-recurring expenses. See slide titled "Reconciliation from GAAP net loss to Adjusted EBITDA" for a reconciliation of Adjusted EBITDA to net loss and the calculation of Adjusted EBITDA Margin 3) Preliminary estimated unaudited financial results as of, or for the year ended 2020. Actual results may differ materially from this preliminary estimated data $119-$123 Preliminary 2020 Range (3) 22#23-> Significant growth in IHE volume driving HCS top-line Home & Community Services - IHE Volume (in millions) 1.1 signifyhealth. 2019 +27% -1.4 Preliminary 2020 (1) » 1) Preliminary estimated unaudited financial results as of, or for the year ended 2020. Actual results may differ materially from this preliminary estimated data Home & Community Services Revenue ($ in millions) $377 2019 +18 - 19% $444 -$450 Preliminary 2020 Range (1) 23#24ECS performance driven by strong savings rate growth Program Size ($ billions) & Savings Rate (%) 2020 savings rate positively impacted by improved partner performance and selective reconciliation exclusion 2020 program size adversely impacted by COVID-19 $6.1 signifyhealth. 5.3% 2019 7.0- 7.3% $5.0 $5.2 Preliminary 2020 Range (2) Episodes of Care Services Revenue (¹) ($ in millions) $125 2019 +25 - 28% 1) Remedy acquisition completed on 1/15/2019 2) Preliminary estimated unaudited financial results as of, or for the year ended 2020. Actual results may differ materially from this preliminary estimated data $156 - $160 Preliminary 2020 Range (2) 24#25-->Financial highlights Zin signifyhealth. $600-610M Revenue 2020 Preliminary Range (¹) $119-123M Adj. EBITDA 2020 Preliminary Range (1), (2) -20% Adj. EBITDA Margin 2020 Preliminary Range(1), (2), (3) 1) Preliminary estimated unaudited financial results as of, or for the year ended 2020. Actual results may differ materially from this preliminary estimated data 2) We define Adjusted EBITDA as net income (loss) before interest expense, income tax expense, depreciation and amortization and certain items of income and expense, including asset impairment, other (income) expense, net transactions-related expenses, equity-based compensation, remeasurement of contingent consideration, management fees and nonrecurring expenses. See slide titled "Reconciliation from GAAP net loss to Adjusted EBITDA" for a reconciliation of Adjusted EBITDA to net loss and the calculation of Adjusted EBITDA Margin 3) Represents the midpoint of the estimated preliminary range for the year ended 2020 25#26Appendix signifyhealth. 26#27-> Reconciliation from GAAP net loss to Adjusted EBITDA Year Ended December 31 (Audited) $ in millions Net loss Interest expense Income tax expense Depreciation and amortization Asset impairment Equity-based compensation Customer equity appreciation rights Transaction-related expenses Other (2) Adjusted EBITDA Adjusted EBITDA Margin 1) Remedy acquisition completed on 1/15/2019. 2) Other includes remeasurement of contingent consideration, non-recurring expenses, management fees, and other income expense, net 3) Preliminary estimated unaudited financial results as of, or for the year ended 2020. Actual results may differ materially from this preliminary estimated data signifyhealth. 2019 (1) (28.5) 21.2 0.1 66.0 6.4 4.5 -- 22.4 1.2 93.3 18.6% I I I I I Year Ended December 31, 2020 Preliminary and Unaudited Range (³) Low (17.0) 22.0 0.5 62.0 0.5 12.0 12.0 16.0 11.0 119.0 19.8% High (24.0) 23.0 1.0 63.0 1.0 13.0 13.0 17.0 16.0 123.0 20.2% 27